FEATURED
COVID 19 Articles
Aipac halts candidate endorsements amid US backlash against Israel
The American Israel Public Affairs Committee announced it will cease endorsing candidates and making direct contributions, marking a strategic shift amid declining support for Israel in US politics.
Ukraine says Starlink still restricted after Trump says limits lifted
Ukraine’s defense ministry reports continued Starlink connectivity issues despite Trump claiming restrictions were lifted, with drones experiencing connection loss at high speeds during military operations.
Attackers have been exploiting critical Zimbra flaw to steal emails
Microsoft warns that attackers are exploiting a critical Zimbra flaw to remotely execute commands and steal email backups and authentication credentials from organizations worldwide.
Apple changes full-disk access permissions to curb abuse from AI agents
Apple announced changes to macOS privacy settings aimed at restricting third-party app developers’ access to sensitive user data through full-disk access permissions, citing concerns about AI agents’ potential to misuse such privileges.
Trending COVID 19 News
Climate change exposes 580 million children to 20 extra ‘heat-stress days’ every year
A new study finds that 580 million children under age 10 globally face at least 20 additional heat-stress days yearly due to climate change, with south Asia, southeast Asia, and west Africa most severely affected.
France relaxes strict cheese-making rules after prolonged drought
France has temporarily relaxed strict cheese-making regulations for iconic varieties including Comté and Beaufort following a severe summer drought that reduced available forage for dairy herds.
Starwatch: Vega the bright star will light the way to the constellation of Lyra
Vega, the fifth-brightest star in the night sky, serves as a guide to locating Lyra, one of the smallest constellations visible high overhead from the UK after dark.
Plantwatch: Cities make a surprising refuge for threatened UK wildflowers
UK wildflowers, devastated in countryside by intensive farming and development, are finding unexpected refuge in urban areas where low-fertility soils and specialized habitats support their growth.
Dogs blink more often when they see owners blinking, study finds
A study found dogs blink more frequently when observing their owners blinking, suggesting blinking may hold social significance in canine-human interactions.
One asteroid strike may explain two mysteries of Mars’ moon Deimos
An international research team concluded that a single asteroid impact may have created both the large southern depression and smooth, dusty surface of Mars’ moon Deimos, based on computer simulations and recent spacecraft observations.
190-year-old DNA reveals a hidden pangolin species
Researchers have confirmed a previously unrecognized Asian pangolin species, Manis aurita, inhabiting Nepal and Northern India, using 190-year-old DNA from museum specimens to clarify species relationships and aid conservation efforts.
Hertfordshire nature reserves spot rare species during heatwaves
Wildlife volunteers in Hertfordshire recorded rare species during this summer’s heatwaves, including a great white egret and glow-worms unseen for 25 years.
What do heatwaves do to the body and who is most at risk?
Heatwaves stress the body’s systems and pose particular risks to older people, young children, and those with chronic conditions. Health authorities recommend staying hydrated, avoiding peak sun hours, and monitoring vulnerable individuals.
Vaccine breakthrough stops cancer returning in trial
A personalized vaccine combined with an immunotherapy drug extended cancer-free survival in melanoma patients during a trial, though full results remain pending peer review and regulatory approval.
First patient to have brain surgery with real-time AI assistance
A patient in the UK became the first person to undergo brain surgery with real-time AI assistance, successfully having a pituitary tumor removed with the AI system helping surgeons avoid critical blood vessels and nerves.
FDA approves landmark pancreatic cancer drug that’s shown to improve survival
The FDA approved daraxonrasib, a first-of-its-kind drug for advanced pancreatic cancer that nearly doubled survival time in clinical trials. The treatment costs approximately $39,800 monthly and blocks a mutated protein present in over 90% of pancreatic cancer cases.